Fund Holdings — JOHNSON & JOHNSON

Total Portfolio Value:
$503.92M
Total Bought:
$891.4K
Total Sold:
$26.29M
Net Transaction:
-$25.40M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Protagonist Therapeutics Inc.2,449,1832,449,1830$136.40M$162.70M32.29%+$26.30M
Nanobiotix S.A.ADS(NBTX)5,623,8165,623,8160$25.45M$106.23M21.08%+$80.78M
MeiraGTx Holdings plc(MGTX)6,641,0646,641,0640$43.90M$54.66M10.85%+$10.76M
Rapport Therapeutics, Inc.(RAPP)2,498,0511,784,517-713,534$28.55M$53.00M10.52%+$24.45M
CVRx, Inc.(CVRX)4,103,4304,103,4300$23.88M$33.11M6.57%+$9.23M
Legend Biotech CorporationADS(LEGN)814,586814,5860$28.21M$26.56M5.27%-$1.65M
Contineum Therapeutics, Inc.CL A(CTNM)1,979,1731,979,1730$8.13M$23.26M4.61%+$15.12M
PROCEPT BioRobotics Corporation(PRCT)357,939357,9390$20.37M$12.77M2.54%-$7.60M
Xencor, Inc.(XNCR)748,062748,0620$6.09M$8.77M1.74%+$2.69M
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,5980$3.98M$8.54M1.69%+$4.56M
Fate Therapeutics, Inc.(FATE)3,379,0643,379,0640$3.51M$4.26M0.84%+$743.4K
Neumora Therapeutics, Inc.(NMRA)1,849,4451,849,4450$1.40M$3.37M0.67%+$1.97M
Vor Biopharma Inc.(VOR)1,074,65853,732-1,020,926$1.14M$2.62M0.52%+$1.48M
Rallybio Corporation(RLYB)3,636,3633,636,3630$1.21M$1.81M0.36%+$605.1K
Lyell Immunopharma, Inc.(LYEL)054,887+54,887$0$891.4K0.18%+$891.4K
Nano-X Imaging Ltd.
ORD SHS
158,852158,8520$830.8K$587.8K0.12%-$243.0K
Standard BioTools Inc.(LAB)311,967311,9670$371.2K$405.6K0.08%+$34.3K
Adicet Bio, Inc.364,472364,4720$228.0K$295.3K0.06%+$67.3K
Tessera Defense and Homeland Security Inc.(HLSQ)96,86696,8660$42.6K$50.9K0.01%+$8.2K
Senseonics Holdings, Inc.(SENS)54,62154,6210$27.0K$23.8K0.00%-$3.2K
Lyell Immunopharma, Inc.(LYEL)41,1650-41,165$368.0K$0—-$368.0K
Page 1 of 1
JOHNSON & JOHNSON — 13F Holdings — Q3 2025 | TickerTrail